Treatment of Hypertension and Metabolic Syndrome: Lowering Blood Pressure Is Not Enough for Organ Protection, New Approach-Arterial Destiffening

Current Hypertension Reports

Volumn 16, Issue 10, 2014, Pages

  Zimlichman, Reuven ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Arterial stiffness; Arteriosclerosis; Atherosclerosis; Blood pressure; Cardiovascular risk factors; Collagen; Elastin; End organ damage; Vascular aging; Vascular disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLAGEN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; ELASTIN; SPIRONOLACTONE;

AGING; ALCOHOL CONSUMPTION; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE; ENDOTHELIAL DYSFUNCTION; HEREDITY; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OSTEOPOROSIS; PULSE PRESSURE; REVIEW; RISK FACTOR; SYMPATHETIC TONE; ANIMAL; ARTERY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECTS;

ANIMALS; ARTERIES; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; RISK FACTORS;

EID: 84930278602     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0479-z     Document Type: Review

References (21)

1. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb. 1993;13:90–7.
2. Lakatta EG. Cardiovascular regulatory mechanism in advanced age. Physiol Rev. 1993;73:413–67.
3. Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol. 1991;139:1119–29.
4. Najjar SS, Scuteri A, Lakatta EG. Arterial aging is it an immutable cardiovascular risk factor. Hypertension. 2005;46:454–62.
5. Laurent S, Lacolley P, Girerd X, et al. Arterial stiffening opposing effects of age and hypertension associated structural changes. Can J Physiol Pharmacol. 1996;74:842–9.
6. Vlachopoulos C, Aznaouridis K, O’Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central hemodynamics: a systematic review and meta–analysis. Eur Heart J. 2010;31:1865–71.
7. Sethi S, Rivera O, Oliveros R, et al. Aortic stiffness: pathophysiology, clinical implications, and approach to treatment. Integr Blood Press Control. 2014;7:29–34. A review that focuses on the pathophysiology involved in aortic stiffness, methods of its evaluation, the importance of central pressure and therapeutic approach to arterial stiffening.
8. Laurent S, Cockroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;2:2558–605.
9. Boutouryie P, Lacolley P, Briet M, et al. Pharmacological modulation of arterial stiffness. Drugs. 2011;71:1689–701.
10. Ong KT, Delerme S, Pannier B, et al. Aortic stiffness is reduced beyond blood pressure lowering by short term and long term antihypertensive treatment: a meta–analysis of individual data in 294 patients. Hypertension. 2011;29:1034–42.
11. Boutouyrie P, Achouba A, Trunet P, Laurent S, EXPLOR trialist group. Amlodipine–valsartan combination decreases central systolic blood pressure more effectively than the amlodipine–atenolol combination: the EXPLOR study. Hypertension. 2010;55:1314–22.
12. Laurent S, Boutouryie P. Recent advances in arterial stiffness and wave reflection in human hypertension: hypertension highlights. Hypertension. 2007;49:1202–6.
13. Tropeano AI, Boutouryie P, Pannier B, et al. Brachial pressure independent reduction in carotid stiffness after long term angiotensin converting enzyme inhibition in diabetic hypertensives. Hypertension. 2006;48:80–6.
14. Benetos A, Locolley P, Safar MF. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1997;17:1152–6.
15. Safar ME, London GM. The arterial system in human hypertension. In Swales J D ed. Textbook of Hypertension, London UK: Blackwell Scientific: 1994: 85–102.
16. Nilsson PM, Boutouryie P, Cunha P, et al. Early vascular aging in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens. 2013;31:1517–26. A comprehensive review that summarizes early vascular ageing and how it can be used in clinical practice.
17. Rizos EC, Agouridis AP, Elisaf MS. The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. Curr Vasc Pharmacol. 2010;8:638–44.
18. Nilsson PM, Boutouryie P, Laurent S. Vascular aging a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009;54:3–10.
19. Rajkumar C, Kingwell BA, Cameron JD, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol. 1997;30:350–6.
20. Wagenseil JE, Mecham RP. Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res. 2012;5:264–73. A review that discusses how alterations in the properties of elastic fibers affect arterial stiffness and blood pressure.
21. Ponticos M, Smith BD. Extracellular matrix synthesis in vascular disease: hypertension and atherosclerosis. J Biomed Res. 2014;28:25–39. A review that summarizes the cellular, extracellular matrix components and the regulation of collagen with their implications on vascular disease.